Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity and Mortality (HIMM) surveillance

Journal of Infection and Chemotherapy

Volumn 20, Issue 1, 2014, Pages 9-14

  Hong, Kyung Wook ^a   Cheong, Hee Jin ^a   Choi, Won Suk ^b   Lee, Jacob ^c   Wie, Seong Heon ^d   Baek, Ji Hyeon ^e   Kim, Hyo Youl ^f   Jeong, Hye Won ^g   Kim, Woo Joo ^a,h  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Hallym University   (South Korea)

^d The Catholic University of Korea College of Medicine   (South Korea)

^e Inha University School of Medicine   (South Korea)

^f Yonsei University Wonju College of Medicine   (South Korea)

^g Chungbuk National University   (South Korea)

^h Transgovernmental Enterprise for Pandemic Influenza   (South Korea)

Author keywords

ComplicationS.; Hospitalized; Influenza; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SURVEILLANCE; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUROMUSCULAR DISEASE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK FACTOR; SEASONAL INFLUENZA; SENSITIVITY AND SPECIFICITY; AGED; EPIDEMIOLOGY; HOSPITAL; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; METABOLISM; MIDDLE AGED; SEASON; SOUTH KOREA; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; SEASONS;

EID: 84903707007     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2013.07.001     Document Type: Article

References (36)

1. Rezkalla SH, Kloner RA. Influenza-related viral myocarditis. WMJ 2010;109: 209e13
2. Treanor JJ. Influenza viruses, including avian influenza and swine influenza. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious disease, vol. 7. Philadelphia: Elsevier; 2010. pp. 2265-88
3. Edelen JS, Bender TR, Chin TD. Encephalopathy and pericarditis during an outbreak of influenza. Am J Epidemiol 1974;100:79-84
4. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008;57:1-60
5. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44
6. Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009eApril 2010). Clin Infect Dis 2011;52(Suppl. 1):S75-82
7. Song JY, Cheong HJ, Heo JY, Noh JY, Yong HS, Kim YK, et al. Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial pneumonia. Influenza Other Respi Viruses 2011;5:-535-43
8. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 2011;377:1264-75
9. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl. 2):S27-72 (Pubitemid 46290553)
10. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24 (Pubitemid 24082248)
11. From the global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2013.http://www.goldcopd.org/ [accessed]
12. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143e78
13. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure e definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8: R204-12
14. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis e an overview for clinicians. Crit Care 2005;9:158-69 (Pubitemid 40425441)
15. Belongia EA, Irving SA, Waring SC, Coleman LA, Meece JK, Vandermause M, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. J Am Med Assoc 2010;304:1091-8
16. To KK, Wong SS, Li IW, Hung IF, Tse H, Woo PC, et al. Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection. Postgrad Med J 2010;86:515-21
17. Doshi S, Kamimoto L, Finelli L, Perez A, Reingold A, Gershman K, et al. Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. J Infect Dis 2011;204:1848-56
18. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007;45:1568-75 (Pubitemid 351411840)
19. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. J Am Med Assoc 2004;292:1333-40 (Pubitemid 39223224)
20. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. J Am Med Assoc 2003;289:179-86 (Pubitemid 36068705)
21. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children e diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003-32
22. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980;112:798-811
23. Keren R, Zaoutis TE, Bridges CB, Herrera G, Watson BM, Wheeler AB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. J Am Med Assoc 2005;294: 2188-94 (Pubitemid 41571136)
24. Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine 2007;25:846-55 (Pubitemid 44873160)
25. Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010;5:e9694
26. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: A global pooled analysis. PLoS Med 2011;8:e1001053
27. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451-8
28. Yokota RT, Skalinski LM, Igansi CN, de Souza LR, Iser BP, Reis PO, et al. Risk factors for death from pandemic (H1N1) 2009, southern Brazil. Emerg Infect Dis 2011;17:1467-71
29. Kim B-N, Kwak YG, Moon C-S, Kim Y-S, Kim ES, Lee KS, et al. Pandemic influenza (H1N1 2009) among pregnant Korean women. Infect Chemother 2011;43:55-9
30. Lim ML, Chong CY, Tee WS, Lim WY, Chee JJ. Influenza A/H1N1(2009) infection in pregnancy e an Asian perspective. BJOG 2010;117:551-6
31. Yamada T, Yamada T, Saito T, Sengoku K, Minakami H. No maternal mortality from pandemic (H1N1) 2009 occurred in Japan; 2010. http://www.bmj.com/ content/340/bmj.c1279?tab=responses [accessed 20.06.12]
32. Yang P, Deng Y, Pang X, Shi W, Li X, Tian L, et al. Severe, critical and fatal cases of 2009 H1N1 influenza in China. J Infect 2010;61:277-83
33. Recommendedcompositionof influenzavirus vaccines for use inthe 2012e2013 northern hemisphere influenza season. Wkly Epidemiol Rec 2012;87:83e95
34. Ingram PR, Inglis T, Moxon D, Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med 2010;36:528-32
35. Cuquemelle E, Soulis F, Villers D, Roche-Campo F, Ara Somohano C, Fartoukh M, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med 2011;37:796-800
36. Piacentini E, Sanchez B, Arauzo V, Calbo E, Cuchi E, Nava JM. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study. J Crit Care 2011;26:201-5.